The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of microRNA-206 on G1 arrest by inhibition of CDK4, cyclin C, and cyclin D in melanoma cells.
Robert W Georgantas
Stock Ownership - AstraZeneca
Katie Streicher
Stock Ownership - AstraZeneca
Xiaobing Luo
No relevant relationships to disclose
Wei Zhu
Stock Ownership - AstraZeneca
Zheng Liu
Stock Ownership - AstraZeneca
Philip Brohawn
Stock Ownership - AstraZeneca
Chris Morehouse
Stock Ownership - AstraZeneca
Brandon W Higgs
Stock Ownership - AstraZeneca
Laura Richman
Stock Ownership - AstraZeneca
Bahija Jallal
Stock Ownership - AstraZeneca
Yihong Yao
Stock Ownership - AstraZeneca
Koustubh Ranade
Stock Ownership - AstraZeneca